MedPath

华中药业股份有限公司

Ownership
-
Established
2002-08-12
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

224

NMPA:224

Drug Approvals

Pentoxifylline Injection

Product Name
己酮可可碱注射液
Approval Number
国药准字H20254026
Approval Date
Apr 30, 2025
NMPA

Rocuronium Bromide Injection

Product Name
罗库溴铵注射液
Approval Number
国药准字H20249722
Approval Date
Dec 10, 2024
NMPA

Rocuronium Bromide Injection

Product Name
罗库溴铵注射液
Approval Number
国药准字H20249723
Approval Date
Dec 10, 2024
NMPA

Captopril Tablets

Product Name
卡托普利片
Approval Number
国药准字H20247254
Approval Date
Oct 29, 2024
NMPA

Levocarnitine Injection

Product Name
左卡尼汀注射液
Approval Number
国药准字H20243927
Approval Date
Jun 4, 2024
NMPA

Levocarnitine Injection

Product Name
左卡尼汀注射液
Approval Number
国药准字H20243926
Approval Date
Jun 4, 2024
NMPA

Ambroxol Hydrochloride Injection

Product Name
盐酸氨溴索注射液
Approval Number
国药准字H20213348
Approval Date
May 11, 2021
NMPA

Hydrocortisone Injection

Product Name
氢化可的松注射液
Approval Number
国药准字H42021507
Approval Date
Sep 18, 2020
NMPA

Vitamin B6 Injection

Product Name
维生素B6注射液
Approval Number
国药准字H42021511
Approval Date
Sep 18, 2020
NMPA

Dexamethasone Sodium Phosphate Injection

Product Name
地塞米松磷酸钠注射液
Approval Number
国药准字H42021492
Approval Date
Sep 18, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 23
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.